Evidence map›Paper›PMID 35987941›Full record

ReviewArchives of toxicology2022

A framework for establishing scientific confidence in new approach methodologies.

Anna J van der Zalm, João Barroso, Patience Browne, Warren Casey, John Gordon, Tala R Henry, Nicole C Kleinstreuer, Anna B Lowit, Monique Perron, Amy J Clippinger

Abstract readReview
In one paragraph

Review in Archives of toxicology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review of in vitro approaches for assessing the toxicity of chemical stressors across diverse physiological systems.Toxicological sciences : an official journal of the Society of Toxicology · 2026
    Review
  3. New approach methodologies in neurotherapeutics development.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  4. New approach methodologies (NAMs) for preclinical and translational evaluation of mRNA-lipid nanoparticle (LNP) therapeutics.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Application of new approach methods (NAMs) in food safety with considerations for new proteins.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2026
    Review
  18. Article
  19. Article
  20. Review

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Anna J van der ZalmPETA Science Consortium International e.V., Stuttgart, Germany. AnnaZ@thepsci.eu.ORCID 0000-0003-0756-918X
João BarrosoEuropean Commission, Joint Research Centre (JRC), Ispra, Italy.
Patience BrowneOrganisation for Economic Co-Operation and Development, Hazard Assessment and Pesticides Programmes, Environmental Directorate, Paris, France.
Warren CaseyNational Institutes of Health, Division of the National Toxicology Program, National Institutes of Environmental Health Sciences, Research Triangle Park, NC, USA.
John GordonU.S. Consumer Product Safety Commission, Directorate for Health Sciences, Rockville, MD, USA.
Tala R HenryU.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics, Washington, DC, USA.
Nicole C KleinstreuerNational Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, Research Triangle Park, NC, USA.
Anna B LowitU.S. Environmental Protection Agency, Office of Pollution Prevention and Toxics, Washington, DC, USA.
Monique PerronU.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, USA.
Amy J ClippingerPETA Science Consortium International e.V., Stuttgart, Germany.

Funding

NIEHS NIH HHS ES103318-06
6 · The paper itself

Abstract

Robust and efficient processes are needed to establish scientific confidence in new approach methodologies (NAMs) if they are to be considered for regulatory applications. NAMs need to be fit for purpose, reliable and, for the assessment of human health effects, provide information relevant to human biology. They must also be independently reviewed and transparently communicated. Ideally, NAM developers should communicate with stakeholders such as regulators and industry to identify the question(s), and specified purpose that the NAM is intended to address, and the context in which it will be used. Assessment of the biological relevance of the NAM should focus on its alignment with human biology, mechanistic understanding, and ability to provide information that leads to health protective decisions, rather than solely comparing NAM-based chemical testing results with those from traditional animal test methods. However, when NAM results are compared to historical animal test results, the variability observed within animal test method results should be used to inform performance benchmarks. Building on previous efforts, this paper proposes a framework comprising five essential elements to establish scientific confidence in NAMs for regulatory use: fitness for purpose, human biological relevance, technical characterization, data integrity and transparency, and independent review. Universal uptake of this framework would facilitate the timely development and use of NAMs by the international community. While this paper focuses on NAMs for assessing human health effects of pesticides and industrial chemicals, many of the suggested elements are expected to apply to other types of chemicals and to ecotoxicological effect assessments.

Indexed as

EcotoxicologyPesticidesAnimalsHumansResearch DesignRisk AssessmentPesticidesFrameworkHuman healthNAMsNew approach methodologiesRegulatoryValidation

Identifiers

PMID35987941
PMCPMC9525335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.